Eosinophilic esophagitis may be due to missing protein

Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE).

Illustration of an eosinophil. Image credit: NIAID

People with EoE experience difficult or painful swallowing, vomiting and nutritional problems because an accumulation of immune cells called eosinophils scars the esophagus.

The researchers found that the protein, SPINK7, was nearly absent in esophageal biopsies taken from adults and children with active EoE but was prevalent in biopsies from healthy people. In a healthy esophagus, SPINK7 tamps down inflammation and helps preserve tissue structure.

Encouragingly, a licensed drug for emphysema reversed damaging inflammation in tissues lacking SPINK7.

Because food contains enzymes that can damage human tissue, the lining of the esophagus normally protects itself by producing its own enzymes that degrade the offending proteins and thus protect the lining. Researchers led by Marc E. Rothenberg, M.D., Ph.D., at Cincinnati Children’s found that SPINK7 facilitates this protective process.

When they silenced SPINK7, the gene that codes for SPINK7, in cells derived from esophageal tissues, the research team discovered that large gaps formed between the cells lining the esophagus. These cells also lost barrier functions that ordinarily move food along the digestive tract.

Tissues that did not express SPINK7 also produced high levels of chemical messengers called cytokines that attract eosinophils and produce the same type of inflammation seen in allergic diseases.

The research team then treated esophageal tissue samples with alpha-1 anti-trypsin, or A1AT, a drug approved to treat an inherited form of emphysema. Like SPINK7, A1AT is a natural inhibitor of specific tissue-damaging proteins.

In the lab, A1AT reversed the damaging inflammation seen in tissues that lacked SPINK7, suggesting that further investigation is warranted to determine if this therapeutic may also benefit people with EoE.

Currently, therapies available to people with EoE include taking corticosteroids to relieve inflammatory symptoms, restricting their diets to avoid allergen-containing foods that may exacerbate the condition, or undergoing periodic surgical procedures to expand the esophagus. (National Institutes of Health)

YOU MAY ALSO LIKE

A healthy lifestyle cuts stroke risk, irrespective of genetic risk

People at high genetic risk of stroke can still reduce their chance of having a stroke by sticking to a healthy lifestyle, in particular stopping smoking and not being overweight.

Connectome map more than doubles human cortex’s known regions

Researchers have mapped 180 distinct areas in our brain’s outer mantle, or cortex – more than twice the number previously known.

Preschoolers benefit from peanut allergy therapy

Researchers tested peanut oral immunotherapy in preschool-aged children with a newly diagnosed peanut allergy. After the treatment, most children could eat peanut-containing foods without an allergic reaction.

Study links irregular sleep patterns to metabolic disorders

A new study has found that not sticking to a regular bedtime and wakeup schedule — and getting different amounts of sleep each night — can put a person at higher risk for obesity, high cholesterol, hypertension, high blood sugar and other metabolic disorders.

Researchers have found a link between allergen in red meat and heart disease

A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the arteries of the heart.

Restoring microbes in infants born by cesarean section

Exposing babies delivered by C-section to fluids from the mother’s birth canal enriched the babies’ microbes to levels more typical of babies born vaginally.